ArticleInternational journal of molecular sciences2024

CA-125 KELIM as an Alternative Predictive Tool to Identify Which Patients Can Benefit from PARPi in High-Grade Serous Advanced Ovarian Cancer: A Retrospective Pilot Diagnostic Accuracy Study.

Dimitrios Zouzoulas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.